Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BAY2287411 |
| Trade Name | |
| Synonyms | BAY-2287411|BAY 2287411|Th 227 Anetumab |
| Drug Descriptions |
BAY2287411 is a radioimmunoconjugate consisting of the radionuclide thorium-227 linked to the mesothelin (MSLN) targeting antibody BAY 86-1903 (anetumab), which induces DNA damage and cell cycle arrest, potentially resulting in increased apoptosis, reduced cell viability, and inhibition of tumor growth (PMID: 31064781). |
| DrugClasses | MSLN Antibody 13 |
| CAS Registry Number | NA |
| NCIT ID | C155977 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BAY2287411 | BAY2287411 | 0 | 1 |